BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9720477)

  • 1. Geriatric dysthymia.
    Kocsis JH
    J Clin Psychiatry; 1998; 59 Suppl 10():13-5. PubMed ID: 9720477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder.
    Devanand DP; Nobler MS; Cheng J; Turret N; Pelton GH; Roose SP; Sackeim HA
    Am J Geriatr Psychiatry; 2005 Jan; 13(1):59-68. PubMed ID: 15653941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset dysthymia and personality disturbance among patients in a primary care setting.
    Sansone RA; Wiederman MW; Sansone LA; Touchet B
    J Nerv Ment Dis; 1998 Jan; 186(1):57-9. PubMed ID: 9457148
    [No Abstract]   [Full Text] [Related]  

  • 5. An update on the pharmacotherapeutic strategies for the treatment of dysthymic disorder: a systematic review.
    Quagliato LA; Primavera D; Fornaro M; Preti A; Carta MG; Nardi AE
    Expert Opin Pharmacother; 2023; 24(18):2035-2040. PubMed ID: 37787056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and treatment of dysthymia in elderly patients.
    Bellino S; Bogetto F; Vaschetto P; Ziero S; Ravizza L
    Drugs Aging; 2000 Feb; 16(2):107-21. PubMed ID: 10755327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder.
    Simon NM; Zalta AK; Worthington JJ; Hoge EA; Christian KM; Stevens JC; Pollack MH
    Depress Anxiety; 2006; 23(6):373-6. PubMed ID: 17068858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
    Versiani M
    J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysthymia among the community-dwelling elderly.
    Kirby M; Bruce I; Coakley D; Lawlor BA
    Int J Geriatr Psychiatry; 1999 Jun; 14(6):440-5. PubMed ID: 10398353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of patients with dysthymia and panic disorder: a naturalistic 9-year follow-up study.
    Svanborg C; Wistedt AA; Svanborg P
    Nord J Psychiatry; 2008; 62(1):17-24. PubMed ID: 18389421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the chronological relationship between the onset of dysthymia and major depression influence subsequent response to antidepressants?
    Levitt AJ; Joffe RT; Sokolov ST
    J Affect Disord; 1998 Jan; 47(1-3):169-75. PubMed ID: 9476757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacotherapy algorithm for the treatment of dysthymia in Japan.
    Kitamura H; Yokoyama T; Someya T
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S49-53. PubMed ID: 10560899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dysthymia.
    Buni TM
    J Fam Pract; 1997 Jun; 44(6):528-9. PubMed ID: 9191617
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.
    de Lima MS; Hotoph M; Wessely S
    Psychol Med; 1999 Nov; 29(6):1273-89. PubMed ID: 10616934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 beta production in dysthymia before and after pharmacotherapy.
    Anisman H; Ravindran AV; Griffiths J; Merali Z
    Biol Psychiatry; 1999 Dec; 46(12):1649-55. PubMed ID: 10624546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The undertreatment of dysthymia.
    Shelton RC; Davidson J; Yonkers KA; Koran L; Thase ME; Pearlstein T; Halbreich U
    J Clin Psychiatry; 1997 Feb; 58(2):59-65. PubMed ID: 9062374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dysthymic disorder.
    Dunner DL
    Depress Anxiety; 1998; 8 Suppl 1():54-8. PubMed ID: 9809214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.